|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 18, 2017 ) According to Publisher, the Global Kidney Function Tests market is expected to grow from $1.23 billion in 2016 to reach $1.96 billion by 2023 with a CAGR of 6.9%. Growing incidence of kidney diseases, raising global geriatric population, and increasing prevalence of diabetes are some of the factors fostering the market growth. In addition, increasing health care awareness, technological advancements are some other factors propelling the market growth. On the other hand, strict regulations on product approvals, high costs for treatment are the restraints inhibiting the market growth.
Request Sample Copy at http://www.reportsweb.com/inquiry&RW00011117675/sample
Regular health check-ups for diabetic patients to monitor their kidney function are causing higher demand for Test Type. There are broad ranges of test type available in market such as dilution & concentration tests, clearance tests, urine tests, imaging tests, and visual imaging tests. In this, clearance tests are famous for its cost efficiency, and accurate test results. Growing government initiatives towards healthcare is assisting hospitals to adopt the tests.
North America is estimated to be the dominant one among all, due to developed healthcare infrastructure, government initiatives towards public health care that are expected to drive this dominance. Asia Pacific region is predicted to grow at higher CAGR during the forecast period. The growth is attributed to rise in medical tourism market, increase in prevalence of kidney function disease in countries such as Japan, China, and India are favoring the Asia Pacific market growth.
Some of the key players in global kidney function tests market include Abbott Laboratories, Alere Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Galectin Therapeutics, Inc., IC-Meditech, Inc., Ipsen S.A., Kadmon Corporation, LLC, Laboratory Corporation of America Holdings(LabCorp), Merck Millipore, Metabolic Solutions Development Company, LLC, Otsuka Holdings Co., Ltd., Pfizer Inc., Quest Diagnostics, Randox Laboratories, and Siemens Healthineers.
Test Types Covered:
-Dilution & Concentration Tests
-Clearance Tests
-Urine Tests
-Imaging Tests
-Visual Imaging Tests
End Users Covered:
-Academic Research Laboratories
-Diagnostic Laboratories
-Hospitals
-Other End Users
Inquire before Buying at http://www.reportsweb.com/inquiry&RW00011117675/buying
Regions Covered:
-North America
US
Canada
Mexico
-Europe
Germany
UK
Italy
France
Spain
Rest of Europe
-Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
-South America
Argentina
Brazil
Chile
Rest of South America
-Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
Company Profiling
9.1 Abbott Laboratories
9.2 Alere Inc.
9.3 Baxter International Inc.
9.4 Eli Lilly and Company
9.5 F. Hoffmann-La Roche Ltd
9.6 Galectin Therapeutics, Inc.
9.7 IC-Meditech, Inc.
9.8 Ipsen S.A.
9.9 Kadmon Corporation, LLC
9.10 Laboratory Corporation of America Holdings(LabCorp)
9.11 Merck Millipore
9.12 Metabolic Solutions Development Company, LLC
9.13 Otsuka Holdings Co., Ltd.
9.14 Pfizer Inc.
9.15 Quest Diagnostics
9.16 Randox Laboratories
9.17 Siemens Healthineers
For more information about this report: http://www.reportsweb.com/kidney-function-tests-global-market-outlook-2017-2023
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
